Morten Orebo Holmström

Medicin og biovidenskab

1. Adaptive Immunity 7%
2. Alleles 9%
3. Antibodies 8%
4. Antigens 18%
5. Arginase 50%
6. B-Cell Chronic Lymphocytic Leukemia 8%
7. Bispecific Antibodies 7%
8. Blocking Antibodies 8%
9. Blood Platelets 13%
10. Calnexin 11%
11. Calreticulin 100%
12. Cancer Vaccines 19%
13. Cellular Immunity 8%
14. Clinical Trials 7%
15. Epitopes 27%
16. Exons 33%
17. Follicular Lymphoma 13%
18. Galectin 3 10%
19. Genes 7%
20. Hematologic Neoplasms 24%
21. Immunity 8%
22. Immunoglobulin Heavy Chains 10%
23. Immunosuppressive Agents 11%
24. Immunotherapy 8%
25. INCB018424 28%
26. Indoleamine-Pyrrole 2,3,-Dioxygenase 10%
27. Interferon-alpha 18%
28. Interferons 20%
29. Ligands 22%
30. Major Histocompatibility Complex 10%
31. Melanoma 7%
32. Mutation 46%
33. Neoplasms 74%
34. Nivolumab 10%
35. Pancreatic Neoplasms 14%
36. Peptides 37%
37. Philadelphia Chromosome 11%
38. Polycythemia Vera 15%
39. Primary Myelofibrosis 29%
40. Regulatory T-Lymphocytes 10%
41. Residual Neoplasm 8%
42. Subunit Vaccines 31%
43. T-Lymphocytes 88%
44. Therapeutics 20%
45. Thrombocytopenia 8%
46. Tissue Donors 18%
47. Transforming Growth Factors 16%
48. Tumor Microenvironment 25%
49. Vaccination 51%
50. Vaccines 41%